Obstructive sleep apnea causes systemic inflammation and metabolic syndrome.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Chest

• Publication date

  2005-03-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1378/CHEST.127.3.1074PMID 15764798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation and obstructive sleep apnea syndrome: how many ways do I look at thee?

  2004cited by this paper
• Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome.

  2004cited by this paper
• Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome.

  2004cited by this paper
• Neurological complications after coronary artery bypass grafting related to the performance of cardiopulmonary bypass.

  2004cited by this paper
• Exercise for fun and profit: joint statement on exercise by the American Thoracic Society and the American College of Chest Physicians.

  2004cited by this paper
• Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome.

  2003cited by this paper
• Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome.

  2003cited by this paper
• Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.

  2003cited by this paper
• To blow or not to blow--that is the question.

  2002cited by this paper
• Ambulatory blood pressure after sleep apnoea treatment.

  2002cited by this paper
• The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea.

  2001cited by this paper
• Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli.

  2000cited by this paper
• Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.

  2000cited by this paper
• Obstructive sleep apnoea.

  1999cited by this paper
• Impact of embolization during coronary artery bypass grafting on outcome and length of stay.

  1997cited by this paper

• Early‐to‐Midlife Body Mass Index Trajectories and Obstructive Sleep Apnoea Risk 10 Years Later

  2025cites this paper
• The Correlation Study of Bone Metabolism and Inflammatory Markers with Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea Syndrome

  2025cites this paper
• Objective sleep monitoring at home in older adults: A scoping review

  2024cites this paper
• Neurologic Aspects of Sleep Medicine

  2021cites this paper
• The evaluation of serum tryptophan and kynurenine levels in patients with obstructive sleep apnea syndrome

  2020cites this paper
• Obesity: the major preventable risk factor of obstructive sleep apnea

  2019cites this paper
• The contribution of chronic intermittent hypoxia to OSAHS: From the perspective of serum extracellular microvesicle proteins.

  2018cites this paper
• Association of angiotensin-converting enzyme gene I/D polymorphism with chronic obstructive pulmonary disease: a meta-analysis

  2018cites this paper
• Effects of renal sympathetic denervation on blood pressure, sleep apnoea severity and metabolic indices: a prospective cohort study.

  2017cites this paper
• Biochemical changes in patients of syndrome “Z” after anti-oxidant treatment

  2017cites this paper
• Obesity and Breathing Related Sleep Disorders

  2016cites this paper
• Obesity and Breathing Related Sleep Disorders: Concise Clinical Review

  2015cites this paper
• Prolonged REM sleep restriction induces metabolic syndrome-related changes: Mediation by pro-inflammatory cytokines.

  2015cites this paper
• Lipid profile after long-term APAP in OSA patients

  2015cites this paper
• Sleep Disorders in Chronic Obstructive Pulmonary Disease: Etiology, Impact, and Management

  2015cites this paper
• Circadian clock desynchronisation and metabolic syndrome

  2014cites this paper
• Impact of sleep-disordered breathing treatment on upper airway anatomy and physiology.

  2014cites this paper
• Serum Levels of Adiponectin, C-Reactive Protein and Tumor Necrosis Factor-alpha in Patients with Obstructive Sleep Apnea Syndrome: Effect of Nasal Continuous Positive Airway Pressure

  2012cites this paper
• Obesity and Obstructive Sleep Apnea

  2012cites this paper
• Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome

  2012cites this paper
• Upper Airway Fat Tissue Distribution in Subjects With Obstructive Sleep Apnea and Its Effect on Retropalatal Mechanical Loads

  2012cites this paper
• Early life precursors, epigenetics, and the development of food allergy

  2012cites this paper
• The Right Heart Diaries in Sleep Disordered Breathing

  2011cites this paper
• Association between short sleep duration and the risk of sensitization to food and aero allergens in rural Chinese adolescents

  2011cites this paper
• Post- to pre-overnight sleep systolic blood pressures are associated with sleep respiratory disturbance, pro-inflammatory state and metabolic situation in patients with sleep-disordered breathing.

  2009cites this paper
• The expression of vascular endothelial growth factor in skeletal muscle of patients with sleep disorders

  2009cites this paper
• Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly

  2009cites this paper
• How is Your Sleep: A Neglected Topic for Health Care Screening

  2008cites this paper
• The metabolic syndrome, diabetes and lung dysfunction.

  2008cites this paper
• Relationship between metabolic syndrome and sleep-disordered breathing in patients with cardiovascular disease--metabolic syndrome as a strong factor of nocturnal desaturation.

  2008cites this paper
• Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients

  2008cites this paper
• Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches.

  2008cites this paper
• Comparison of Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels between Patients with and without Obstructive Sleep Apnea Syndrome

  2008cites this paper
• Long-term oxygen administration reduces plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome.

  2007cites this paper
• Effect of Nasal Continuous Positive Airway Pressure Treatment on Plasma Adrenomedullin Levels in Patients with Obstructive Sleep Apnea Syndrome: Roles of Nocturnal Hypoxia and Oxidant Stress

  2007cites this paper
• RETRACTED: Long-term oxygen administration reduces plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome

  2007cites this paper
• Sindrome delle apnee notturne nelle malattie endocrino-metaboliche

  2006cites this paper
• To Sleep, Perchance to Breathe: Sleep Apnea, Snoring, and Sleep-Disordered Breathing

  2006cites this paper
• Obstructive sleep apnea and insulin resistance: a role for microcirculation?

  2006cites this paper
• Improvement of endothelial function with allopurinol may occur in selected patients with OSA: effect of age and sex

  2006cites this paper
• Serum Amyloid A and Obstructive Sleep Apnea Syndrome before and after Surgically-Induced Weight Loss in Morbidly Obese Subjects

  2006cites this paper
• Long-term sleep apnea as a pathogenic factor for cell-mediated autoimmune disease.

  2005cites this paper